People News: Alexion Pharmaceuticals and KV Pharmaceutical

Share this article:
Alexion Pharmaceuticals appointed William Keller to its board of directors, effective immediately, bringing to eight the number of members. Keller is founder and general manager of Keller Pharma Consultancy, based in China, and serves as a senior consultant to the Shanghai Foreign Investment Development Board, as well as deputy general manager of Zhangjiang Biotech & Pharmaceutical Base Development Co. From 1976 to 2003, he held various positions with Roche Group in Asia and South America.

Specialty firm KV Pharmaceutical named David Van Vliet CEO, with a term through December 31, 2011. Van Vliet has served as interim president and CEO since December 2008.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media